GENE ONLINE|News &
Opinion
Blog

2026-05-06|

Stabilis Solutions Q1 2026 Revenue Up to $23.4 Million, Net Loss Increases to $10.4 Million

by GOAI
Share To

Stabilis Solutions reported their first quarter results for 2026, showing revenue increases alongside higher net losses compared to the previous year. The company also detailed its operational expenses and capital expenditures for the quarter.

Specifically, Stabilis Solutions announced revenues of $23.4 million, which marks an increase from the $19.1 million reported in the first quarter of 2025. However, the company’s net loss also increased, reporting a net loss of $10.4 million, or $0.24 per share, compared to a net loss of $6.4 million, or $0.16 per share, in the same period last year. The company’s operational expenses totaled $8.8 million, and capital expenditures reached $3.9 million during the quarter.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: May 6, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Ellomay Capital Completes Sale of Dorad Energy Holdings on May 10, 2026
2026-05-10
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10
India’s Pharmaceutical Growth Slows: Industry Needs New Strategies
2026-05-10
MoonLake Immunotherapeutics Concludes Pre-BLA Meeting with FDA and Reports Q1 2026 Financial Results
2026-05-10
New Method Allows Repeated Genetic Data Extraction From Living Cells Without Destruction
2026-05-10
Scroll to Top